Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

LGND

Market Cap$1.97B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class BLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B-14.8--17%11.6-
$155.00

Target Price by Analysts

48.8% upsideLigand Pharmaceuticals Target Price DetailsTarget Price
$76.60

Current Fair Value

26.5% downside

Overvalued by 26.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.97 Billion
Enterprise Value$1.94 Billion
Dividend Yield$0 (0%)
Earnings per Share$-0.22
Beta0.76
Outstanding Shares19,191,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-14.79
PEG9.91
Price to Sales11.58
Price to Book Ratio2.54
Enterprise Value to Revenue10.67
Enterprise Value to EBIT-54.85
Enterprise Value to Net Income-15
Total Debt to Enterprise0.01
Debt to Equity0.02

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Ligand Pharmaceuticals, Inc.

CEO: John Higgins